Strata Oncology's mission is to transform cancer care through large-scale molecularly-informed clinical research.
Strata for Health Systems
Advanced Clinical Research and Care for the Precision Oncology Era
Our precision oncology platform provides a comprehensive, streamlined solution centered on a systematic, rather than individual physician-led, approach to deliver a new, precision oncology standard of care. By deploying a clinical research-driven model for precision oncology that supports enterprise-wide access and continuous learning, our partners are leading the way in cancer clinical research and care.
Strata for Biopharma
Cancer Drug Development
for the Precision Oncology Era
We offer biopharmaceutical partners the most efficient path to new and expanded precision drug approvals. Our pioneering approach includes access to a network of trial ready sites and the largest clinical-genomic database of trial candidates, potentially eligible for immediate enrollment, to provide an unprecedented ability to learn from real-world evidence and rapidly translate insights to active prospective studies.
Strata Precision Oncology Network
The leading network for investigators and biopharma to design and conduct potentially
transformative precision cancer therapy studies.
In the News
Strata Oncology Secures $26M Series B Funding, Led by Pfizer and Merck
Strata Oncology, a precision oncology platform company, today announced the close of a $26 million USD Series B funding round. Read more.
Strata Oncology Aims to Streamline Molecular Testing, Clinical Trial Enrollment for Cancer Patients
Strata Oncology is on its way toward analyzing tumor profiles of more than 10,000 patients this year... Read more.